Complementarity of gluCEST and $^1$H‐MRS for the study of mouse models of Huntington's disease

Archive ouverte

Pépin, Jérémy | de Longprez, Lucie | Trovero, Fabrice | Brouillet, Emmanuel | Valette, Julien | Flament, Julien

Edité par CCSD ; Wiley -

International audience. Identification of relevant biomarkers is fundamental to understand biological processes of neurodegenerative diseases and to evaluate therapeutic efficacy. Atrophy of brain structures has been proposed as a biomarker, but it provides little information about biochemical events related to the disease. Here, we propose to identify early and relevant biomarkers by combining biological specificity provided by 1H‐MRS and high spatial resolution offered by gluCEST imaging. For this, two different genetic mouse models of Huntington's disease (HD)—the Ki140CAG model, characterized by a slow progression of the disease, and the R6/1 model, which mimics the juvenile form of HD—were used. Animals were scanned at 11.7 T using a protocol combining 1H‐MRS and gluCEST imaging. We measured a significant decrease in levels of N‐acetyl‐aspartate, a metabolite mainly located in the neuronal compartment, in HD animals, and the decrease seemed to be correlated with disease severity. In addition, variations of tNAA levels were correlated with striatal volumes in both models. Significant variations of glutamate levels were also observed in Ki140CAG but not in R6/1 mice. Thanks to its high resolution, gluCEST provided complementary insights, and we highlighted alterations in small brain regions such as the corpus callosum in Ki140CAG mice, whereas the glutamate level was unchanged in the whole brain of R6/1 mice. In this study, we showed that 1H‐MRS can provide key information about biological processes occurring in vivo but was limited by the spatial resolution. On the other hand, gluCEST may finely point to alterations in unexpected brain regions, but it can also be blind to disease processes when glutamate levels are preserved. This highlights in a practical context the complementarity of the two methods to study animal models of neurodegenerative diseases and to identify relevant biomarkers

Suggestions

Du même auteur

In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease

Archive ouverte | Pépin, Jérémy | CCSD

International audience. Huntington's disease (HD) is an inherited neurodegenerative disease characterized by motor, cognitive and psychiatric symptoms. Atrophy of the striatum has been proposed for several years as ...

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin

Archive ouverte | Galvan, Laurie | CCSD

International audience. The neurobiological functions of a number of kinases expressed in the brain are unknown. Here, we report new findings on DCLK3 (doublecortin like kinase 3), which is preferentially expressed ...

Energy defects in Huntington's disease: Why “in vivo” evidence matters

Archive ouverte | Liot, Géraldine | CCSD

International audience

Chargement des enrichissements...